tetano
Editor, Senior Moderator
Trends Immunol. 2020 Apr 2. pii: S1471-4906(20)30057-0. doi: 10.1016/j.it.2020.03.007. [Epub ahead of print]
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
Jiang S[SUP]1[/SUP], Hillyer C[SUP]2[/SUP], Du L[SUP]3[/SUP].
Author information
Abstract
Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
Copyright ? 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
KEYWORDS:
MERS-CoV; SARS-CoV; SARS-CoV-2; human coronaviruses; neutralizing antibodies
PMID:32249063DOI:10.1016/j.it.2020.03.007
Free full text
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
Jiang S[SUP]1[/SUP], Hillyer C[SUP]2[/SUP], Du L[SUP]3[/SUP].
Author information
Abstract
Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
Copyright ? 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
KEYWORDS:
MERS-CoV; SARS-CoV; SARS-CoV-2; human coronaviruses; neutralizing antibodies
PMID:32249063DOI:10.1016/j.it.2020.03.007
Free full text